Listed respiratory healthcare company Fisher & Paykel Healthcare has provided guidance on the first half of the 2025 financial year after a strong year to date across all products and regions.
It has forecast an 18% lift in revenue of between $940 million to $950m for the first half of the 2025
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
